- Home
- TOUR vs GNLX Comparison
TOUR vs GNLX Comparison
Compare TOUR & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOUR
- GNLX
- Stock Information
- Founded
- TOUR 2006
- GNLX 2001
- Country
- TOUR China
- GNLX United States
- Employees
- TOUR N/A
- GNLX N/A
- Industry
- TOUR Transportation Services
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- TOUR Consumer Discretionary
- GNLX Health Care
- Exchange
- TOUR Nasdaq
- GNLX Nasdaq
- Market Cap
- TOUR 122.8M
- GNLX 103.6M
- IPO Year
- TOUR 2014
- GNLX 2023
- Fundamental
- Price
- TOUR $1.07
- GNLX $2.40
- Analyst Decision
- TOUR
- GNLX Strong Buy
- Analyst Count
- TOUR 0
- GNLX 4
- Target Price
- TOUR N/A
- GNLX $18.25
- AVG Volume (30 Days)
- TOUR 226.2K
- GNLX 163.2K
- Earning Date
- TOUR 12-05-2024
- GNLX 11-14-2024
- Dividend Yield
- TOUR N/A
- GNLX N/A
- EPS Growth
- TOUR N/A
- GNLX N/A
- EPS
- TOUR N/A
- GNLX N/A
- Revenue
- TOUR $72,825,718.00
- GNLX $8,000.00
- Revenue This Year
- TOUR $20.26
- GNLX N/A
- Revenue Next Year
- TOUR $15.73
- GNLX N/A
- P/E Ratio
- TOUR N/A
- GNLX N/A
- Revenue Growth
- TOUR 87.48
- GNLX N/A
- 52 Week Low
- TOUR $0.59
- GNLX $1.60
- 52 Week High
- TOUR $1.76
- GNLX $16.60
- Technical
- Relative Strength Index (RSI)
- TOUR 49.65
- GNLX 40.85
- Support Level
- TOUR $1.01
- GNLX $2.48
- Resistance Level
- TOUR $1.09
- GNLX $2.80
- Average True Range (ATR)
- TOUR 0.07
- GNLX 0.19
- MACD
- TOUR -0.00
- GNLX -0.03
- Stochastic Oscillator
- TOUR 52.38
- GNLX 15.38
About TOUR Tuniu Corporation
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. All the company's revenues are derived from within the People's Republic of China.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.